Skin Anarchy·2d agoWhy Most Longevity Medicine Is Just a Rebrand with Dr. Vali — E.885Longevity medicine has become one of the fastest-growing areas of health and aesthetics, introducing consumers to everything from…
InILLUMINATIONbyHair Loss, Explained·Sep 11I Co-Wrote a Review of Exosomes for Hair Loss. Here Is What We Could Not Find.Nobody can tell you what was in the syringe. That turns out to be a bigger problem than whether it works.A response icon2A response icon2
Skin Anarchy·Jun 4The Exosome Question with David Panter of RadiantXO — E.851Regenerative medicine has rapidly become one of the most influential areas shaping the future of skincare, but few topics have generated as…
Skin Anarchy·Mar 5A Breakthrough in Exosome Skincare ft. Madhavi Gavini of Droplette — E.830In this special return episode of Skin Anarchy, host Dr. Ekta Yadav welcomes back Madhavi Gavini, the founder of Droplette — one of the…A response icon1A response icon1
Po-Sung (Sinclair) Huang·Jan 11What Investors Should Ask When a Biology Startup Shows Beautiful StructuresHow AlphaFold 3-era biology can quietly distort risk for biotech investors.
Po-Sung (Sinclair) Huang·Jan 7Why Exosome Therapies Keep Showing Effects — but Rarely Produce TargetsEffects without drivers in the age of AI biology.
Po-Sung (Sinclair) Huang·Dec 25, 2025# Causality in the Age of AI Biology## A manifesto for when plausibility is no longer enough
Po-Sung (Sinclair) Huang·Dec 15, 2025# AF³ Series: Healing in Practice — From Superstable Proteins to Overnight Cures### *Why the “Healing Layer” is not just a concept, but a concrete path to hope.*
InThe Eta Zeta Biology JournalbyCarolyn Stum·Dec 2, 2025Application of Exosomes in Joint InflammationOsteoarthritis is a condition that involves damage to tissue in joints and degeneration. This occurs through inflammation. There are…
Stem Cell Journal·Oct 24, 2025The FDA has spoken. The question is: Are you listening?In the past year, the FDA’s Center for Biologics Evaluation and Research (CBER) issued at least 12 formal warning letters to companies in…
